Home
About Nanexa
Pharmashell®
Projects
Investors
Media
Contact
English
- Swedish

Extraordinary General Meeting, 13th of February 2025

28 January, 2025 - Bolagsstämma

Extraordinary General Meeting, 13th of February 2025

Bilagor

Notice of EGM 13 February 2025

Nanexa is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell® – the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. Nanexa develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

CONTACT

Nanexa AB, Virdings Allé 2, SE-75450 Uppsala, Sweden
Phone: +46 (0) 18 100 300
E-mail: info@nanexa.se
Org nr. 556833-0285

Integritetspolicy
Integritetspolicy för aktieägare

English
Svenska